ABIO Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
ABIO enterprise value is not available.ABIO Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Enterprise Value Performance
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
6 m6 months | - | - | - |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
ABIO Enterprise Value High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | ||||
6 m | 6-month | $691 M | $385 M | ||
1 y | 1-year | $691 M | $239 M | ||
3 y | 3-year | $691 M | $238 M | ||
5 y | 5-year | $797 M | $36 M | ||
alltime | all time | $21 B | $36 M |
ARCA Biopharma Enterprise Value History
Date | Value |
---|---|
2023 | $258.60 M(-29.7%) |
2022 | $367.66 M(+15.3%) |
2021 | $318.80 M(-22.4%) |
2020 | $410.80 M(+307.2%) |
2019 | $100.88 M(+105.4%) |
2018 | $49.12 M(-73.0%) |
2017 | $182.06 M(-40.0%) |
2016 | $303.23 M(-35.0%) |
2015 | $466.21 M(+105.6%) |
2014 | $226.73 M(-24.3%) |
2013 | $299.49 M(+329.0%) |
2012 | $69.82 M(-50.2%) |
2011 | $140.11 M(-57.5%) |
Date | Value |
---|---|
2010 | $329.44 M(+13.2%) |
2009 | $290.94 M(+46.8%) |
2008 | $198.24 M(-82.5%) |
2007 | $1.13 B(-54.5%) |
2006 | $2.48 B(-41.4%) |
2005 | $4.24 B(+13.1%) |
2004 | $3.75 B(+15.6%) |
2003 | $3.25 B(+1247.9%) |
2002 | $240.79 M(-85.6%) |
2001 | $1.68 B(-28.7%) |
2000 | $2.35 B(-15.1%) |
1999 | $2.77 B(+229.1%) |
1998 | $841.59 M(-45.7%) |
1997 | $1.55 B |
FAQ
- What is the all time high enterprise value for ARCA biopharma?
What is the all time high enterprise value for ARCA biopharma?
ARCA biopharma all-time high enterprise value is $20.61 B